Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Plus Therapeutics, Inc. (PSTV) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Plus Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1095981.
Total stock buying since 2015: $894,205.
Total stock sales since 2015: $1,135,091.
Total stock option exercises since 2015: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 110,000 | $53,790 | 0 | $0 | 0 | $0 |
2024 | 184,738 | $348,604 | 0 | $0 | 0 | $0 |
2023 | 55,088 | $97,360 | 0 | $0 | 0 | $0 |
2022 | 65,000 | $39,420 | 4,500 | $1,416 | 0 | $0 |
2021 | 36,913 | $70,702 | 0 | $0 | 0 | $0 |
2020 | 36,700 | $91,167 | 0 | $0 | 0 | $0 |
2018 | 0 | $0 | 898,412 | $311,075 | 0 | $0 |
2016 | 158,500 | $46,024 | 0 | $0 | 0 | $0 |
2015 | 409,849 | $147,138 | 600,000 | $822,600 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-08 | 110,000 | $53,790 | 0 | $0 | 0 | $0 |
2024-09 | 39,883 | $53,104 | 0 | $0 | 0 | $0 |
2024-05 | 144,855 | $295,500 | 0 | $0 | 0 | $0 |
2023-11 | 24,594 | $39,198 | 0 | $0 | 0 | $0 |
2023-09 | 26,993 | $44,080 | 0 | $0 | 0 | $0 |
2023-06 | 1,000 | $3,980 | 0 | $0 | 0 | $0 |
2023-05 | 2,500 | $9,102 | 0 | $0 | 0 | $0 |
2023-03 | 1 | $1,000 | 0 | $0 | 0 | $0 |
2022-12 | 0 | $0 | 4,500 | $1,416 | 0 | $0 |
2022-06 | 20,000 | $11,835 | 0 | $0 | 0 | $0 |
2022-05 | 30,000 | $16,500 | 0 | $0 | 0 | $0 |
2022-04 | 13,000 | $8,885 | 0 | $0 | 0 | $0 |
2022-03 | 2,000 | $2,200 | 0 | $0 | 0 | $0 |
2021-11 | 1,000 | $1,864 | 0 | $0 | 0 | $0 |
2021-10 | 17,000 | $28,988 | 0 | $0 | 0 | $0 |
2021-09 | 7,000 | $13,013 | 0 | $0 | 0 | $0 |
2021-07 | 4,230 | $8,357 | 0 | $0 | 0 | $0 |
2021-04 | 2,183 | $4,970 | 0 | $0 | 0 | $0 |
2021-03 | 5,500 | $13,510 | 0 | $0 | 0 | $0 |
2020-12 | 2,500 | $4,975 | 0 | $0 | 0 | $0 |
2020-11 | 2,200 | $4,708 | 0 | $0 | 0 | $0 |
2020-08 | 27,000 | $70,984 | 0 | $0 | 0 | $0 |
2020-06 | 5,000 | $10,500 | 0 | $0 | 0 | $0 |
2018-02 | 0 | $0 | 709,986 | $242,079 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-22 | Lenk Robert P | Buy | 110,000 | .49 | 53,790 |
2024-09-13 | Hawkins Richard J | Buy | 4,000 | 1.50 | 5,996 |
2024-09-12 | Hawkins Richard J | Buy | 6,285 | 1.35 | 8,509 |
2024-09-11 | Clowes Howard | Buy | 5,000 | 1.34 | 6,680 |
2024-09-11 | Petersen Greg | Buy | 12,500 | 1.35 | 16,875 |
2024-09-10 | Sims Andrew John Hugh Macintyre (Chief Financial Officer) | Buy | 4,098 | 1.27 | 5,204 |
2024-09-10 | Hedrick Marc H (Chief Executive Officer) | Buy | 8,000 | 1.23 | 9,840 |
2024-05-08 | Clowes Howard | Buy | 19,608 | 2.04 | 40,000 |
2024-05-08 | Sims Andrew John Hugh Macintyre (Chief Financial Officer) | Buy | 9,804 | 2.04 | 20,000 |
2024-05-08 | Petersen Greg | Buy | 24,510 | 2.04 | 50,000 |
2024-05-08 | Lenk Robert P | Buy | 8,334 | 2.04 | 17,000 |
2024-05-08 | Hawkins Richard J | Buy | 9,804 | 2.04 | 20,000 |
2024-05-08 | Hedrick Marc H (Chief Executive Officer) | Buy | 24,510 | 2.04 | 50,000 |
2023-11-16 | Lenk Robert P (Director) | Buy | 1,000 | 1.95 | 1,950 |
2023-11-15 | Lenk Robert P (Director) | Buy | 1,000 | 1.77 | 1,770 |
2023-11-13 | Lenk Robert P (Director) | Buy | 4,000 | 1.43 | 5,720 |
2023-11-10 | Lenk Robert P (Director) | Buy | 2,000 | 1.45 | 2,900 |
2023-11-09 | Lenk Robert P (Director) | Buy | 4,199 | 1.59 | 6,676 |
2023-11-08 | Lenk Robert P (Director) | Buy | 5,000 | 1.65 | 8,250 |
2023-11-07 | Lenk Robert P (Director) | Buy | 6,000 | 1.64 | 9,840 |
2023-11-06 | Lenk Robert P (Director) | Buy | 1,395 | 1.50 | 2,092 |
2023-09-13 | Clowes Howard (Director) | Buy | 6,993 | 1.43 | 10,020 |
2023-09-11 | Petersen Greg (Director) | Buy | 20,000 | 1.70 | 34,060 |
2023-06-06 | Clowes Howard (Director) | Buy | 1,000 | 3.98 | 3,980 |
2023-05-03 | Clowes Howard (Director) | Buy | 2,500 | 3.64 | 9,102 |
2023-03-03 | Hawkins Richard J (Director) | Buy | 1 | 1,000.00 | 1,000 |
2022-12-30 | Lenk Robert P (Director) | Sale | 3,000 | .32 | 944 |
2022-06-15 | Hedrick Marc H (Chief Executive Officer) | Buy | 5,000 | .65 | 3,240 |
2022-06-02 | Clowes Howard (Director) | Buy | 15,000 | .57 | 8,595 |
2022-05-17 | Petersen Greg (Director) | Buy | 30,000 | .55 | 16,500 |
2022-04-26 | Sims Andrew John Hugh Macintyre (Chief Financial Officer) | Buy | 3,000 | .67 | 2,016 |
2022-04-26 | Hedrick Marc H (Chief Executive Officer) | Buy | 7,500 | .69 | 5,159 |
2022-03-01 | Sims Andrew John Hugh Macintyre (Chief Financial Officer) | Buy | 2,000 | 1.10 | 2,200 |
2021-11-02 | Sims Andrew John Hugh Macintyre (Chief Financial Officer) | Buy | 1,000 | 1.86 | 1,864 |
2021-10-27 | Petersen Greg (Director) | Buy | 12,500 | 1.72 | 21,500 |
2021-10-26 | Sims Andrew John Hugh Macintyre (Chief Financial Officer) | Buy | 2,000 | 1.67 | 3,338 |
2021-10-26 | Hedrick Marc H (Chief Executive Officer) | Buy | 2,500 | 1.66 | 4,150 |
2021-09-13 | Lenk Robert P (Director) | Buy | 7,000 | 1.86 | 13,013 |
2021-07-28 | Sims Andrew John Hugh Macintyre (Chief Financial Officer) | Buy | 2,244 | 1.91 | 4,286 |
2021-07-27 | Sims Andrew John Hugh Macintyre (Chief Financial Officer) | Buy | 1,986 | 2.05 | 4,071 |
2021-04-30 | Hedrick Marc H (Chief Executive Officer) | Buy | 2,183 | 2.28 | 4,970 |
2021-03-04 | Hedrick Marc H (Chief Executive Officer) | Buy | 2,500 | 2.50 | 6,250 |
2021-03-03 | Clowes Howard (Director) | Buy | 3,000 | 2.42 | 7,260 |
2020-12-10 | Hedrick Marc H (Chief Executive Officer) | Buy | 2,500 | 1.99 | 4,975 |
2020-11-30 | Hedrick Marc H (Chief Executive Officer) | Buy | 2,200 | 2.14 | 4,708 |
2020-08-25 | Lenk Robert P (Director) | Buy | 3,000 | 2.49 | 7,464 |
2020-08-13 | Petersen Greg (Director) | Buy | 10,000 | 2.80 | 28,000 |
2020-08-12 | Petersen Greg (Director) | Buy | 10,000 | 2.52 | 25,200 |
2020-08-12 | Hedrick Marc H (Chief Executive Officer) | Buy | 4,000 | 2.58 | 10,320 |
2020-06-22 | Hedrick Marc H (Chief Executive Officer) | Buy | 5,000 | 2.10 | 10,500 |
2018-02-14 | Postfinance Ag (10% Owner) | Sale | 473,831 | .34 | 161,102 |
2018-02-09 | Postfinance Ag (10% Owner) | Sale | 7,552 | .34 | 2,567 |
2018-02-08 | Postfinance Ag (10% Owner) | Sale | 228,603 | .34 | 78,410 |
2018-01-11 | Swissquote Bank Sa | Sale | 72,630 | .34 | 24,694 |
2018-01-10 | Swissquote Bank Sa | Sale | 15,796 | .38 | 6,002 |
2018-01-09 | Swissquote Bank Sa | Sale | 100,000 | .38 | 38,300 |
2016-08-10 | Harris John David (VP and GM Cell Therapy) | Buy | 2,500 | 2.03 | 5,074 |
2016-06-14 | Naughton Gail K | Buy | 1,000 | 2.10 | 2,100 |
2016-06-14 | Rickey David | Buy | 5,000 | 2.10 | 10,500 |
2016-03-09 | Rickey David | Buy | 150,000 | .19 | 28,350 |
2015-09-03 | Thompson Tommy G | Buy | 25,449 | .38 | 9,543 |
2015-09-02 | Hayden Jeremy B. (General Counsel & VP of BD) | Buy | 8,200 | .35 | 2,911 |
2015-08-28 | Hedrick Marc H (President and CEO) | Buy | 1,200 | .31 | 372 |
2015-08-28 | Rickey David | Buy | 56,000 | .32 | 17,640 |
2015-08-27 | Hedrick Marc H (President and CEO) | Buy | 10,000 | .30 | 3,050 |
2015-08-27 | Rickey David | Buy | 50,000 | .30 | 14,950 |
2015-08-26 | Rickey David | Buy | 25,000 | .33 | 8,175 |
2015-08-21 | Hedrick Marc H (President and CEO) | Buy | 10,000 | .36 | 3,650 |
2015-08-21 | Rickey David | Buy | 50,000 | .38 | 18,750 |
2015-08-20 | Hedrick Marc H (President and CEO) | Buy | 10,000 | .40 | 4,000 |
2015-08-19 | Kesten Steven (Exec VP and Chief MO) | Buy | 6,000 | .39 | 2,322 |
2015-08-19 | Hayden Jeremy B. (General Counsel & VP of BD) | Buy | 18,000 | .39 | 7,056 |
2015-08-19 | Rickey David | Buy | 48,600 | .39 | 19,099 |
2015-08-18 | Girao Tiago (VP & Chief Financial Officer) | Buy | 25,000 | .39 | 9,750 |
2015-08-18 | Hedrick Marc H (President and CEO) | Buy | 10,000 | .39 | 3,920 |
2015-08-18 | Rickey David | Buy | 51,400 | .39 | 20,200 |
2015-04-06 | Lim Kian Thiam (10% Owner) | Sale | 600,000 | 1.37 | 822,600 |
Insider trading activities including stock purchases, stock sales, and option exercises of PSTV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Plus Therapeutics, Inc. (symbol PSTV, CIK number 1095981) see the Securities and Exchange Commission (SEC) website.